Ceramide, a product of sphingomyelin hydrolysis, is now recognized as an intracellular lipid messenger, which mediates the effects of extracellular agents on cellular growth, differentiation and apoptosis. Recently, ceramide has been implicated in the regulation of phospholipase D (PLD). In this study, we examined the effects of ceramide on the activity and mRNA level of PLD during apoptotic process in FRTL-5 thyroid cells. C 2 -ceramide (N-acetyl sphingosine) induced apoptosis in FRTL-5 thyroid cells. Fluorescent staining showed that ceramide induced the typical features of apoptosis including condensed or fragmented nuclei. DNA fragmentation was also observed by agarose gel electrophoresis. Flow cytometric cell cycle analysis showed more clearly that ceramide induced apoptotic cell death in FRTL-5 thyroid cells. The treatment of FRTL-5 thyroid cells with thyroid-stimulating hormone (TSH) resulted in an increased PLD activity in a dose-and time-dependent manner. However, the TSH-induced increase in PLD activity was down-regulated within 2 h after ceramide treatment. Furthermore, the levels of PLD mRNA were found to be decreased throughout apoptotic process as inferred by reverse transcription-polymerase chain reaction. However, the decreases in PLD mRNA levels were not correlated with those in PLD activities after ceramide treatment. Taken together, these data suggest that ceramide inhibits the PLD activity in an early apoptotic phase and down-regulation of the levels of PLD mRNA may be implicated in apoptotic process in FRTL-5 thyroid cells.
Introduction
Signal transduction system generating phospholipid metabolites constitutes one of the most important systems for the generation of second messenger to regulate cell growth. Phospholipase D (PLD) plays a key role in signal transduction and its activation occurs in a wide range of cell types in response to hormones and growth factors and is implicated in the regulation of inflammatory and immune response, cellular trafficking, and cell growth (Exton, 1994) . PLD catalyzes the hydrolysis of cell phospholipid, mainly phosphatidylcholine (PC), resulting in the formation of phosphatidic acid (PA), which acts by itself as cellular messenger (Exton, 1990) or can be transformed by PA phosphohydrolase into diacylglycerol (DAG), which is essential for the activation of protein kinase C (PKC) (Nishizuka, 1995) .
Programmed cell death or apoptosis is a process of active cellular self-destruction that plays an indispensable role in the development and maintenance of homeostasis in multicellular organisms (Clarke, 1990) . Its hallmark biochemical feature is endonuclease activation, giving rise to DNA fragmentation (Wyllie et al., 1980) . There are also characteristic morphologic changes, including chromatin condensation, nuclear fragmentation and shrinkage, and the formation of dense chromatin masses (apoptotic body) Morris et al., 1984; Stacey et al., 1985) . Recent investigations indicate that signaling events following cellular exposure to tumor necrosis factor α (TNFα), Fas ligand, glucocorticoids, irradiation and other DNAdamaging agents seem to converge in intracellular signals that result in apoptosis (Arends and Wyllie, 1991; Williams and Smith, 1993; Hoffman and Liebermann, 1994; Wyllie, 1995) Ceramide has recently emerged as an important intracellular mediator for cell growth, differentiation and programmed cell death in a growing number of cell types Kolensnick and Fuks, 1995; Testi, 1996) . Ceramide biosynthesis is initiated by hydrolysis of the phospholipid, sphingomyelin, which is preferentially localized to the outer leaflet of the plasma membrane (Spiegel et al., 1996) . Cellular exposure to TNFα, Fas ligand, irradiation, and other DNA-damaging agents may trigger apoptosis via the hydrolysis of membrane sphingomyelin generating ceramide (Bielawska et al., 1993; Haimovitz-Freidman et al., 1994; Gamen et al., 1996) . However, the apoptotic effects of TNFα and ceramide are inhibited by simultaneous addition of phorbol esters or DAG which are activators of PKC (Obeid et al., 1993; . The opposing effects of ceramide and DAG on viability/apoptosis suggest that the decision of cells to live or die may be a result of the relative contribution of at least two distinct signal transduction pathways involving DAG and ceramide, respectively. It is well known that DAG can be generated by the rapid conversion of PA produced by PLD acting on PC as well as from phosphoinositide (PI) by PI-specific phospholipase C (Liscovitch, 1991; Venable et al., 1994) . Furthermore, accumulating evidences show that the action of PC-PLD followed by PA phosphohydrolase results in more sustained DAG production (Liscovitch, 1991) . Recently, it has been also reported that C 2 -ceramide inhibited PLD activity in rat basophilic leukemia cells (Nakamura et al., 1996) , in rat fibroblast (Gomez-Munoz et al., 1994; Jones and Murray, 1995) , and in cell-free systems using HL-60 cells (Venable et al., 1996) . C 6 -ceramide also inhibited PLD activity and DAG accumulation in human diploid fibroblast (Venable et al., 1994) . However, to our knowledge, no reports have been available about ceramide-induced apoptosis and effect of ceramide on PLD activity in thyroid cell. In thyroid cells, apoptosis is suspected of being involved in the regulation of normal glandular size and appears to be one of the major modes of thyrocyte death in autoimmune thyroid disease (Kotani et al., 1995; Tanimoto et al., 1995) . With these premises, in the present study we have examined the effects of ceramide on apoptotic cell death and the possibility that PLD may be involved in apoptotic cell death in FRTL-5 thyroid cells. Cell culture FRTL-5 thyroid cells were cultured in Coon's modified Ham's F-12 medium supplemented with 5% newborn calf serum and six-hormone mixture (6H) comprised of bovine insulin (10 µg/ml), hydrocortisone (0.36 ng/ml), human transferrin (5 µg/ml), glycyl-L-histidyl-L-lysine acetate (10 µg/ml), somatostatin (10 µg/ml), and TSH (2 mU/ml), as previously described (Mori et al., 1996) . Cells were maintained at 37 o C in an atmosphere saturated with water and containing 95% air-5% CO 2 . When confluence was reached, cells were trypsinized and subcultured to 6-well tissue culture plates. After the cells reached to confluence, the medium was changed to 5H medium (6H medium devoid of TSH), and the cells were incubated for a further 6 days. The culture medium was changed twice weekly. On the day of the experiment, the medium was replaced with Coon's modified Ham's F-12 medium without any additional hormones.
Materials and Methods

Materials
Fluorescent staining of apoptotic nuclei
After the indicated incubation periods, the cells were treated with mild hypertonic solution (distilled water : PBS; 1 : 1, v/v) for 10 min. The cells were prefixed in 50% solution of fixative (methanol : acetic acid; 3 : 1, v/ v) for 5 min and followed by fixation for 10 min. After fixation, the cells were stained with acridine orange (1 µg/ml) for 10 min. The stained cells were rinsed and observed with a fluorescence microscope (Diaphot 300 attached with epi-fluorescence, Nikon).
DNA fragmentation analysis
Equivalent number (10 5 ) of cells were seeded into each well of 6 well plates and grown in 6H medium. After the indicated incubation periods, the total cell population (adherent and detached cells) were collected and lysed in 1 ml of 100 mM NaCl, 10 mM Tris-HCl pH 8.0, 25 mM EDTA, 0.5% SDS. Lysates were incubated for 4 h at 56 o C with 0.2 mg/ml proteinase K. After extraction with equal volume of phenol/chloroform/isoamyl alcohol (25 : 24 : 1, v/v), followed by re-extraction with chloroform/ isoamyl alcohol (24 : 1, v/v). DNA was precipitated by addition of 0.1 volume of 3 M sodium acetate, pH 5.3, and one volume of isopropanol and incubation at -70 o C for at least 1 h. Precipitated DNA was collected by centrifugation at 14,000 g for 30 min at 4 o C, washed with ice-cold 80% ethanol and air-dried. DNA was then resuspended in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA (TE buffer) and treated with 0.5 mg/ml RNase at 37 o C. DNA samples were fractionated by electrophoresis in a 1.5% TBE-agarose gel at 100 V and visualized by ethidium bromide staining.
Flow cytometric analysis
Cells were treated with 50 µM C 2 -ceramide or ethanol (vehicle) for 12 h. Cells were then harvested by trypsinization, washed once in PBS and fixed with ice-cold 70% ethanol at 4 o C for 30 min. Fixed cells were stained in 1 ml of propidium iodide (50 µg/ml) in PBS containing 0.1% Trition X-100, 0.1 mM EDTA (Na) 2 , and 50 µg/ml (50 U/mg) of DNase-free RNase and subject-ed to flow cytometry on a FACScan (Becton-Dickinson, NJ, U.S.A.) using CELL Quest TM software.
Determination of PLD activity PLD activity was determined by measuring the accumulation of [ 3 H]-phosphatidylethanol (PEt), since this is the product of its transphosphatidylation reaction which is considered to be a definitive assay for PLD (Exton, 1990) . FRTL-5 thyroid cells were washed three times with modified Ham's F-12 medium and then incubated in serum-free modified Ham's F-12 medium containing 0.1% albumin and 2 µCi/well of [ 3 H]-myristate for 4 h. The reaction medium was aspirated, and the cells were washed twice with nonradioactive Ham's mediumalbumin solution. The FRTL-5 thyroid cells were then incubated for a further 2 h in medium containing 0.5% albumin with three changes of medium. The medium was then replaced with medium containing 0.1% albumin and 1% (v/v) ethanol. TSH at the indicated concentration was added after 5 min incubation, and the cells were incubated for the times specified. To determine the effect of ceramide on TSH-mediated PLD activity, the cells were pretreated with various concentrations of ceramide for the indicated times and then treated TSH in the presence of 1% ethanol. Incubation was performed at 37 o C and terminated by washing the cells twice with ice-cold PBS and immediately adding 0.5 ml of ice-cold methanol. Cells were collected by scraping and the dishes were washed with an additional 0.5 ml of ice-cold methanol. Lipids were then extracted essentially as described by Bligh and Dyer (1959) , and PEt was separated from other phospholipids by thin layer chromatography (TLC) on silica gel 60 plates with the organic phase of the solvent system: ethyl acetate/ 2,2,4-trimethylpenthan/acetic acid/water (110 : 50 : 20 : 100, v/v). Unlabeled PEt was run together with samples and the corresponding lipid spot was identified by exposure to 0.002% (w/v) primulin in 80% (v/v) acetone, scraped and then counted using a scintillation counter.
RNA extraction and RT-PCR
Total cellular RNA was isolated using RNAzol TM (Biotecx Lab, TX, U.S.A.), according to the manufacturer's instruction. RNA (2.5 µg) was subjected to cDNA synthesis using avian myoblastosis virus (AMV) reverse transcriptase (Promega, WI, U.S.A) in the supplied buffer system and oligo(dT)-primer. Synthesis was performed at 42 o C for 60 min followed by denaturation of the cDNA strands at 95 o C for 5 min. Samples were cooled rapidly to 4 o C and 2-4 µl were used for PCR. RT-PCR was performed using Taq DNA polymerase (TaKaRa Shuzo, Japan) in the supplied buffer system with 0.2 mM dNTP mixture and relevant primers. PCR primer set for PLD was 5'-CGGTGGCGTTTGTGGGT-GGGA-3' (sense) and 5'-GTCCTTGAAGACAAAGTTG-CA-3' (antisense). The PCR primer set for β-actin was 5'-TTGATACCAACTGGGACGATATGG-3' (sense) and 5'-GATCTTGATCTTCATGGTGCTAGG-3' (antisense). Numbers of amplification cycles were determined for individual primer sets to maintain exponential rate of product amplification. The number of cycles determined for β-actin was 30, for PLD was 28, respectively. Amplified DNA fragments were subjected to electrophoresis on 1.5% agarose gel and visualized by ethidium bromide staining. Intensity of bands was quantified by a densitometry.
Results
Ceramide induced apoptotic cell death in FRTL-5 thyroid cells
To ascertain whether ceramide initiates an apoptotic response in FRTL-5 thyroid cells, experiment was carried out using the synthetic ceramide analogue C 2 -ceramide (N-acetyl sphingosine). Incubation of FRTL-5 thyroid cells for 12 h with 50 µM C 2 -ceramide produced typical apoptotic changes of nuclear condensation, fragmentation, and apoptotic body formation, detected by staining with fluorescent dye, acridine orange ( Figure  1 ). In addition to the typical morphological changes, ceramide-induced apoptosis in FRTL-5 thyroid cells was also demonstrated by agarose gel electrophoresis of DNA extracted from treated cells. Treatment with 50 µM C 2 -ceramide produced a typical ladder pattern of oligonucleosomal fragments (Figure 2) . To identify the subpopulation of FRTL-5 thyroid cells undergoing apoptosis, flow cytometry was performed in cells stained with propidium iodide. This method makes it possible to correlate the presence of fluorescing DNA breaks in individual cells with their DNA ploidy and position in the cell cycle. Control cells incubated for 12 h under the same culture conditions had DNA ploidy of A 0 phase in 7.38% of the cells (Figure 3 ). On the other hand, treatment with 50 µM C 2 -ceramide for 12 h resulted in the appearance of cells exhibiting apoptotic DNA fragmentation and 37.6% of the total population of treated cells showed apoptotic fluorescence (A 0 ). These data clearly demonstrated that ceramide induced apoptotic cell death in FRTL-5 thyroid cells.
Effect of ceramide on TSH-induced PLD activity
It has been reported that TSH induces thyroid growth and differentiation via metabolic pathway controlling the activity of PLD (Lejeune et al., 1996) . First of all, to determine whether TSH increases the PLD activity, FRTL-5 thyroid cells were incubated with TSH (100 µU/ ml) and the PLD activities after various times of exposure were monitored (Figure 4) . A significant change of PLD activity was seen as early as 10 min after exposure to TSH. PLD activity was significantly increased after TSH treatment at each time point examined, with maximal response after 120 min exposure to TSH. In addition to these results, a doseresponse curve for TSH revealed maximum PLD activity at 100 µU/ml TSH compared to control values ( Figure  5 ). To determine the modulatory role of ceramide on the action of TSH in PLD activation, the effect of C 2 -ceramide (0-50 µM) on the stimulation of PLD activity by TSH was then evaluated in FRTL-5 thyroid cells. As shown in Figure 6 , TSH-induced PLD activity was not significantly affected at 1 h after ceramide treatment except for 50 µM C 2 -ceramide. On the other hand, ceramide substantially suppressed the PLD activity at 2 h after exposure. These results indicated that TSH could stimulate PLD activity and the TSH-induced PLD activation was perturbed completely by ceramide within 2 h after treatment.
Changes in mRNA expression of PLD Because TSH-induced increase of PLD activity was decreased in an early phase of ceramide-induced apoptosis, we also examined the changes of gene expression for PLD by RT-PCR throughout the apoptotic process. No significant changes were observed in levels of β-actin mRNA (reference control) throughout the time course (Figure 7) , whereas the treatment of ceramide (50 mM) decreased mRNA levels of PLD in a timedependent manner. The temporal profile of TSHdependent PLD activity, however, was not correlated with those of the mRNA levels of PLD after exposure to ceramide. 
Discussion
In the last few years, experimental evidence has been provided for a signaling role exerted by sphingoid molecules including ceramide. Among the multiple pathways which are regulated by these substances, the control of PLD activity may represent a crucial step, in view of the ability of this enzyme to affect the levels of key lipid mediators such as PA and DAG (Exton, 1994; Nishizuka, 1995) .
Sphingomyelin pathway has been claimed to be involved in the apoptotic process and ceramide, the product of sphingomyelin hydrolysis by sphingomyelinase, appears to be a functional mediator of this pathway Ballou et al., 1996; Testi, 1996) . In this present study, we demonstrated for the first time that ceramide induces apoptosis in FRTL-5 thyroid cells, although it has been known to induce apoptosis in hematopoietic cells, fibroblast (Obeid et al., 1993) , neurons (Brugg et al., 1996) and reproductive cells (Kaipia et al., 1996; Witty et al., 1996) . Drastic morphological changes were observed in ceramidetreated cells. Cellular processes were retracted gradually and cells became round when examined under a phase-contrast microscopy (Data not shown). In addition, typical apoptotic changes, such as nuclear fragmentation, chromatin condensation and apoptotic body formation, were observed by acridine-orange staining.
DNA fragmentation was confirmed by agarose gel electrophoresis. Flow cytometric analysis showed more clearly that ceramide induced apoptotic cell death in FRTL-5 thyroid cells. Recently, several studies demonstrated that apoptosis was involved in cell death of normal thyrocyte and thyroid diseases such as goiter (Tamura et al., 1998) and thyroiditis (Kotani et al., 1995) , and also suggested that the mechanisms by which thyroid cells undergo apoptosis were mediated by Fas/Fas ligand system (Arscott et al., 1997; Tamura et al., 1998) . In consideration of several findings indicating that sphingomyelin pathway is involved in Fasmediated apoptotic signaling in various type of cells (Gulbins et al., 1995; Tepper et al., 1997; Boesen-de Cock et al., 1998) , our results also suggested that ceramide may play a role in Fas-mediated apoptosis in thyroid cells.
Recently, many investigators have demonstrated that ceramide inhibits PLD activity in a number of cells including rat basophilic leukemia cells (Nakamura et al., 1996) , rat fibroblast (Gomez-Munoz et al., 1994; Jones and Murray, 1995) and C6 glial cells (Yoshimura et al., 1997) . Because PLD activation is involved in cell The number of amplification cycles determined for β-actin was 30, for PLD was 28, respectively to maintain the exponential rate of product amplification. Amplified DNA fragments were subjected to electrophoresis on 1.5% agarose gel and visualized by ethidium bromide staining (A). Intensity of bands was quantified by a densitometer and expressed as mean±SE values from three different experiments (B).
proliferation and differentiation Klein et al., 1995; Liscovitch and Cantley, 1995) , it is tempting to examine that inhibition of PLD activity would be implicated in induction of apoptotic cell death by ceramide.
Our results showed that TSH, a key growth factor for thyroid cell, induced an increase of PLD activity and that TSH-induced PLD activation was decreased with doseand time-dependent manners after addition of ceramide. These results indicated that the PLD pathway could be an important target for the modulation of signal transduction by ceramide. Although the exact mechanism of this effect is unclear at present, considering PLD activity is regulated by Arf, Rho (Bowman et al., 1993; Brown et al., 1993; Cockcroft et al., 1994; Malcolm et al., 1994) and PKC (Balboa et al., 1994) , it is possible that ceramide may inhibit translocation of these PLD activator to membrane, leading to a decrease in PLD activity. In addition, it is well known that PA produced by PLD from PC may act as a potent mitogen in cells (Exton, 1994; Spiegel and Milstien, 1996) . This is followed by DAG generation via a PA phosphohydrolase and then DAG activates PKC. Therefore, it is possible that ceramide-induced inhibition of PLD activity attenuates PA production and subsequent DAG accumulation, and results in insufficient PKC activation for cell growth. Accordingly, we propose that ceramide may play an important role in inhibiting mitogenic pathway in an early phase during apoptotic process.
We next examined expression of mRNAs of PLD in FRTL-5 thyroid cells treated with ceramide. Ceramide inhibited PLD gene expression in a time-dependent manner and mRNA of PLD was not detected by RT-PCR at 12 h after exposure to ceramide. However, down-regulation of PLD gene expression was not correlated with ceramide-induced decreases in PLD activity. Therefore, decreased PLD activity might not be a result from decreased levels of PLD mRNA, and it is possible that these two events might be regulated by different mechanisms during ceramide-induced apoptotic process.
In summary, our results indicated that ceramide induced apoptotic changes in FRTL-5 thyroid cell and also suggested that inhibition of PLD activity by ceramide might be involved in the induction of apoptotic process. Moreover, our results demonstrated that mRNA levels of PLD were decreased time-dependently during ceramide-induced apoptosis. Thus, ongoing investigations of the mechanism(s) mediating the action of ceramide on PLD activity and gene expression will contribute to enhanced understanding of apoptotic signaling pathway. Furthermore, our results provide new insight regarding potential regulatory mechanism between the two important lipid-mediated pathway of signal transduction, namely the ceramide signaling pathway and PLD signaling pathway in apoptosis.
